| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 116.16B | — |
| Operating expense | — | — |
| Net income | 24.15B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, OPHLY returned +36.5% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +11.9% |
| 1 year | +36.5% |
| 5 years | -33.4% |
| 10 years | -38.3% |
| All-time high | $15.30 (Apr 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in OPHLY would be worth today ›No. Ono Pharmaceutical Co., Ltd. has not paid a dividend in the past 12 months.
Ono Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Ono Pharmaceutical Co., Ltd. has a market cap of 7.18B USD, based on the latest quote.
